[go: up one dir, main page]

IS5663A - A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or NADHP - Google Patents

A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or NADHP

Info

Publication number
IS5663A
IS5663A IS5663A IS5663A IS5663A IS 5663 A IS5663 A IS 5663A IS 5663 A IS5663 A IS 5663A IS 5663 A IS5663 A IS 5663A IS 5663 A IS5663 A IS 5663A
Authority
IS
Iceland
Prior art keywords
carnitine
nadhp
nadh
alkanoyl
composition
Prior art date
Application number
IS5663A
Other languages
Icelandic (is)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of IS5663A publication Critical patent/IS5663A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5663A 1998-04-17 2000-10-13 A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or NADHP IS5663A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (en) 1998-04-17 1998-04-17 COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH
PCT/IT1999/000088 WO1999053921A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Publications (1)

Publication Number Publication Date
IS5663A true IS5663A (en) 2000-10-13

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5663A IS5663A (en) 1998-04-17 2000-10-13 A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or NADHP

Country Status (17)

Country Link
EP (1) EP1071424A1 (en)
JP (1) JP2002512191A (en)
KR (1) KR20010042765A (en)
CN (1) CN1299283A (en)
AU (1) AU750645B2 (en)
BR (1) BR9909712A (en)
CA (1) CA2328331A1 (en)
EE (1) EE200000601A (en)
HU (1) HUP0101914A3 (en)
IL (1) IL139014A0 (en)
IS (1) IS5663A (en)
IT (1) IT1299161B1 (en)
NO (1) NO20005128L (en)
PL (1) PL343482A1 (en)
SK (1) SK15442000A3 (en)
TR (1) TR200002894T2 (en)
WO (1) WO1999053921A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (en) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Dietary supplement, e.g. for increasing general performance, concentration and endurance, comprises NADH, L-carnitine, coenzyme Q10, L-carnosine, succinic acid, ascorbic acid and bioflavonoids
AU2007353211B2 (en) * 2007-05-11 2013-08-29 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel useful for the delivery of cosmetic active ingredients
WO2011022786A1 (en) * 2009-08-31 2011-03-03 Pharmaqest Pty Ltd Methods for diagnosis and treatment of chronic fatigue syndrome
CN104306390A (en) * 2014-10-23 2015-01-28 苏州人本药业有限公司 Application of reduced coenzyme II
CN104840479A (en) * 2015-02-17 2015-08-19 苏州人本药业有限公司 Application of NADPH in preparation of drugs used for treating heart diseases
US10894059B2 (en) * 2017-12-22 2021-01-19 Bontac Bio-Engineering (Shenzhen) Co., Ltd NADH compound composition, and preparation and use thereof
EP3755160B1 (en) 2018-04-20 2021-11-03 Pacotrade AG Device for crushing deep-frozen foodstuffs provided in block form
CN109170907A (en) * 2018-08-30 2019-01-11 泓博元生命科技(深圳)有限公司 A kind of preparation method of composition containing NMN, application and sports drink
CN109105702A (en) * 2018-08-30 2019-01-01 泓博元生命科技(深圳)有限公司 A kind of preparation method of composition containing NADH, application and energy extender
JP7199518B2 (en) * 2018-10-10 2023-01-05 蘇娥 梁 Health care product composition for deficit compensation, method of making and use thereof
CN117958433A (en) * 2024-03-22 2024-05-03 四川新渔新美健康科技有限公司 Caffeine-free anti-fatigue functional composition and beverage

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (en) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (en) * 1993-10-19 1995-04-20 Schleicher Peter Geriatric medical composition
JPH09110708A (en) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd Nutritional tonic crude drug combination preparation
JPH0959161A (en) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd Fatigue improving composition
IT1277953B1 (en) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND A 3-OMEGA SERIES POLYUNSATURED ACID USEFUL
IT1283951B1 (en) * 1996-03-15 1998-05-07 Mendes Srl USE OF ACETYL L-CARNITINE OR ITS PHARMACOLOGICALLY ACCEPTABLE SALTS FOR THERAPEUTIC TREATMENT OR PROPHYLAXIS OF
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (en) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd Fatigue improver

Also Published As

Publication number Publication date
BR9909712A (en) 2000-12-26
HUP0101914A2 (en) 2002-03-28
ITRM980238A1 (en) 1999-10-17
IL139014A0 (en) 2001-11-25
IT1299161B1 (en) 2000-02-29
AU750645B2 (en) 2002-07-25
AU3442899A (en) 1999-11-08
SK15442000A3 (en) 2001-06-11
CN1299283A (en) 2001-06-13
PL343482A1 (en) 2001-08-27
NO20005128L (en) 2000-12-18
NO20005128D0 (en) 2000-10-12
HUP0101914A3 (en) 2002-12-28
EE200000601A (en) 2002-04-15
JP2002512191A (en) 2002-04-23
TR200002894T2 (en) 2001-01-22
CA2328331A1 (en) 1999-10-28
EP1071424A1 (en) 2001-01-31
WO1999053921A1 (en) 1999-10-28
KR20010042765A (en) 2001-05-25
ITRM980238A0 (en) 1998-04-17

Similar Documents

Publication Publication Date Title
DE69933825D1 (en) Chemically amplified positive resist composition
DE69905371D1 (en) HARDENABLE COMPOSITION
NO991151D0 (en) Compound and Use thereof
IS5850A (en) Antioxidant composition comprising acetyl L-carnitine and alpha-lipoic acid
SG79263A1 (en) Adhesive composition and adhesive sheet
HUP0104270A3 (en) Herbicidal composition and use thereof
DE69933544D1 (en) POLYMER AND HARDENABLE COMPOSITION
EP0989459A4 (en) Chemically amplified resist composition
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
NO20006488D0 (en) Composition and application
NO20022334L (en) New composition and application
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
DE69831605T2 (en) ANTI-ESTROGEN AND PROGESTINE-CONTAINING ORAL CONTRAZEPTIVA
DK1112003T3 (en) New composition and application
EP1096316A4 (en) Positive resist composition
PT1139761E (en) HERBICID AND CONCENTRATED COMPOSITIONS
DE69908455D1 (en) inserter
IL138178A0 (en) Identifiable marking compositions and methods
EP1117084A4 (en) Music notation implement and music
IS5663A (en) A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or NADHP
EP1056455A4 (en) Epimorphian compound and its use
MA26666A1 (en) ANTIOXIDE, ANTIPROLIFERATE COMPOSITION, INCLUDING CARNITINE AND CAROTENOIDE.
GB9803232D0 (en) Compound composition and use
NO20006626D0 (en) Coating agent and its use
PL338379A1 (en) Novel photoinitiators and their application